Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...
Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...
CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for ...
Novo Nordisk received approval from the U.S. FDA for the Wegovy pill (once-daily oral semaglutide 25 mg) to reduce excess ...
BioMarin adds scale of operations, including global commercial footprint and in-house manufacturing capabilities for rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback